中文 | English
Return
Total: 303 , 1/31
Show Home Prev Next End page: GO
Author:(Cheng-ying JIANG)

2.Application of proteomics technologies pharmacology and toxicology mechanismsof in traditional Chinese medicine compatibility study

Hanxing CHENG ; Aihua SUN ; Ying JIANG

Chinese Journal of Pharmacology and Toxicology 2015;(6):973-978

3.The DSA findings and embolization treatment of broncho-costoarterial pulmonary circulation fistula

Cheng-Jiang XIAO ; Pei-Ying WEI ;

Journal of Interventional Radiology 1994;0(02):-

4.BIOSYNTHESIS OF POLYHYDROXYALKANOATES BY RHODOCISTA PEKINGENSIS

Wei ZHANG ; Cheng-Ying JIANG ; Xin DAI ; Shuang-Jiang LIU ;

Microbiology 1992;0(01):-

5.Survey on and Phytogeny of Alicyclobacillus Species in Hot Springs of Southern China's Guangdong and Yunna Provinces

Zhi-Wei CHEN ; Cheng-Ying JIANG ; Shuang-Jiang LIU ;

Microbiology 1992;0(03):-

6.Clinical observation of gemcitabine combined with S -1capsule on patients with advanced esophageal cancer

Liyuan JIANG ; Caixia ZHAO ; Yanguang FENG ; Zhiyong CHENG ; Ying HAN

Practical Oncology Journal 2014;(1):30-33

7.Formulation Optimization of Transferrin Modified Tetrandrine and Vincristine Liposomes by Central Com-posite Design-response Surface Method

Ying JIANG ; Xiaomin WANG ; Yanhong WANG ; Lan CHENG ; Xuetao LI

China Pharmacy 2015;26(31):4399-4401

8.Study on Anti-tumor Effects of Vinblastine Hydrophilic Group Modified Cationic Liposomes in Tumor-bearing Mice

Xuetao LI ; Lan CHENG ; Ying JIANG ; Rongping YU ; Lianqun JIA

China Pharmacy 2015;26(31):4339-4341

9.Analysis and Suggestions of Key Technical Requirements of Wuhan Biopharmaceutical Industry

Hong JIANG ; Xiaofeng LIU ; Tianming DING ; Ying CHENG

China Pharmacist 2016;19(9):1730-1732

10.Determination of Content and Entrapment Efficiency of Transferrin Modified Vincristine-Tetrandrine Lipo-somes

Xuetao LI ; Wei TANG ; Ying JIANG ; Lan CHENG

China Pharmacy 2016;27(22):3034-3036

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 303 , 1/31 Show Home Prev Next End page: GO